Bank OZK is scheduled to release its Q3 2026 earnings after market close on October 20, providing investors with updated financial results to compare against Citigroup's current Sell rating. The bank's latest balance sheet shows $41.70 billion in total assets, $35.40 billion in liabilities, and $6.28 billion in stockholders' equity. Citigroup currently rates the stock as Sell, with the price at $45.59. Management will hold a Q&A call on October 21 to discuss the results and outlook.
Bank OZK's Q3 2026 earnings preview comes as 54 of 85 Financials-sector US stocks on Pluang rose today. For readers following financial stocks, here is Pluang's market snapshot as of Oct 07, 2026 01:11 WIB: BBVA traded at USD 27.35 with a 1-day change of +1.52% and 100% buy order activity, LU at USD 1.01 with -1.46% and 89% sell order activity, and SPGI at USD 396.60 with +1.45% and 100% buy order activity. Typical hold times ranged from 13 to 123 days.
Stryker experienced an 8.8% stock drop on September 8, 2026, wiping out over $10 billion in market value due to ongoing manufacturing problems that were thought resolved. Truist Financial lowered its price target from $340 to $310, reflecting concern...
Scotiabank has increased its price target for Pfizer stock from $30.00 to $33.00, suggesting a potential upside of 20.9% from the current trading price of $27.31. Pfizer, a major pharmaceutical company, holds a strong buy rating with a Zacks Rank of ...
Citigroup has raised its price target for AstraZeneca to £186.00 from £178.00, maintaining a Buy rating following successful Phase 3 clinical trials. The increase reflects higher peak sales forecasts for drugs tozorakimab and SERENA-6, offsetting the...
An analyst from BMO Capital set a $67 price target for Devon Energy, suggesting a 40% upside from its current share price of around $48. The oil and gas producer has consistently beaten earnings estimates recently, showing strong financial health. Ho...
An investment of $10,000 in Marvell stock a decade ago has grown to approximately $206,000 today. Achieving the same growth again would require an annual earnings increase of 35%. This highlights Marvell's strong past performance and the challenge of...
